- Merrimack Pharmaceuticals (NASDAQ:MACK): Q2 EPS of -$0.17 beats by $0.13.
- Revenue of $27.82M (+50.8% Y/Y) beats by $16.8M.
- Press Release
Merrimack Pharmaceuticals beats by $0.13, beats on revenue
Recommended For You
More Trending News
About MACK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MACK | - | - |
| Merrimack Pharmaceuticals, Inc. | ||